Ryan Specialty (NYSE:RYAN) Announces Quarterly Earnings Results

Ryan Specialty (NYSE:RYAN) released its quarterly earnings results on Thursday. The company reported $0.74 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.14, FiscalAI reports. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The firm had revenue of $916.65 million for the quarter, compared to analyst estimates of $873.93 million. During the same quarter in the previous year, the company posted $0.66 EPS. The business’s revenue was up 7.2% on a year-over-year basis.

Here are the key takeaways from Ryan Specialty’s conference call:

• Second-quarter results exceeded expectations, with revenue up 7.2% to $917 million, organic growth of 6.7%, adjusted EBITDA up 6% to $327 million, and adjusted EPS up 12.1% to $0.74. First-half organic growth reached 8.9%, while management raised its full-year organic growth outlook to the higher end of the mid-single-digit range.
• Ryan Specialty repurchased 8.1 million shares for $260 million during the quarter, authorized an additional $300 million for buybacks, and repurchased another $42 million in July. Net leverage ended at 3.3 times, within management’s targeted 3-to-4-times range.
• The company expects continued pressure from declining property pricing, heightened competition in casualty and binding authority, builders-risk headwinds, and a difficult third-quarter comparison. Full-year adjusted EBITDA margin is now expected to decline approximately 50 to 100 basis points, reflecting talent investments, lower fiduciary income, and higher healthcare costs.
• Management highlighted strong performance in casualty construction, professional lines, transactional liability, and reinsurance, supported by a robust pipeline and continued specialty-market demand. Investments in AI, alternative capital solutions, benefits, and new underwriting businesses are intended to improve productivity, diversify revenue, and support longer-term growth.
• Management said it is unlikely to close a meaningful acquisition in 2026 and is instead evaluating opportunities for 2027, while maintaining a disciplined approach focused on strategic fit, cultural alignment, and accretion.

Ryan Specialty Stock Performance

NYSE:RYAN traded up $0.95 during trading on Friday, reaching $45.04. The company’s stock had a trading volume of 1,374,162 shares, compared to its average volume of 2,314,661. The firm has a 50 day moving average of $37.51 and a 200-day moving average of $38.39. The company has a debt-to-equity ratio of 2.90, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $11.87 billion, a price-to-earnings ratio of 58.52, a price-to-earnings-growth ratio of 1.01 and a beta of 0.61. Ryan Specialty has a 12 month low of $29.28 and a 12 month high of $61.85.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 25th. Stockholders of record on Tuesday, August 11th will be issued a $0.13 dividend. The ex-dividend date of this dividend is Tuesday, August 11th. This represents a $0.52 annualized dividend and a dividend yield of 1.2%. Ryan Specialty’s dividend payout ratio is currently 67.53%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on RYAN. Wolfe Research lowered shares of Ryan Specialty from an “outperform” rating to a “peer perform” rating in a report on Thursday, July 9th. Barclays boosted their target price on shares of Ryan Specialty from $46.00 to $48.00 and gave the company an “overweight” rating in a report on Friday. Piper Sandler increased their price target on Ryan Specialty from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday. JPMorgan Chase & Co. lifted their price objective on shares of Ryan Specialty from $37.00 to $39.00 and gave the company an “underweight” rating in a research note on Monday, July 13th. Finally, Citigroup decreased their target price on Ryan Specialty from $55.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Eight investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $51.44.

Insiders Place Their Bets

In related news, Chairman Patrick G. Ryan bought 120,000 shares of the company’s stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $32.50 per share, for a total transaction of $3,900,000.00. Following the completion of the purchase, the chairman directly owned 13,817,859 shares in the company, valued at $449,080,417.50. The trade was a 0.88% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director John W. Rogers, Jr. purchased 7,500 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The shares were bought at an average price of $35.16 per share, with a total value of $263,700.00. Following the purchase, the director owned 117,933 shares in the company, valued at $4,146,524.28. The trade was a 6.79% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have purchased 130,715 shares of company stock valued at $4,263,590. Company insiders own 52.03% of the company’s stock.

Institutional Investors Weigh In On Ryan Specialty

Several institutional investors have recently added to or reduced their stakes in the business. Advisory Services Network LLC bought a new position in Ryan Specialty in the 3rd quarter worth approximately $28,000. Los Angeles Capital Management LLC bought a new stake in shares of Ryan Specialty during the 4th quarter valued at $25,000. Quarry LP purchased a new stake in Ryan Specialty during the 3rd quarter worth about $37,000. Caitong International Asset Management Co. Ltd grew its holdings in Ryan Specialty by 173.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company’s stock valued at $37,000 after buying an additional 450 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Ryan Specialty during the second quarter valued at about $56,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty declared that its board has authorized a stock buyback program on Tuesday, May 26th that allows the company to repurchase $300.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 3.5% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Key Headlines Impacting Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q2 earnings and revenue exceeded expectations: Ryan Specialty reported adjusted earnings of $0.74 per share, ahead of estimates ranging from $0.60 to $0.61 and up from $0.66 a year earlier. Revenue increased 7.2% year over year to $916.6 million, surpassing the approximately $874 million consensus estimate. Ryan Specialty Reports Second Quarter 2026 Results
• Positive Sentiment: Analysts raised their outlook: Keefe, Bruyette & Woods increased its price target from $48 to $54 and maintained an “outperform” rating, implying roughly 20% potential upside from the referenced share price. Other analysts also boosted forecasts following the results. Analysts Boost Forecasts on Ryan Specialty
• Neutral Sentiment: Growth guidance remains constructive but mixed: Management expects 2026 organic revenue growth toward the higher end of its mid-single-digit target range, while second-quarter organic growth was 6.7%, slightly below the 7.1% recorded a year earlier. Ryan Specialty 2026 Guidance
• Negative Sentiment: Expected margin pressure is a concern: Ryan Specialty forecasts its 2026 adjusted EBITDAC margin will decline by 50 to 100 basis points, which could weigh on profitability despite continued revenue growth.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.